ArticleRheumatology and therapy2019

Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs.

Alvin F Wells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.